Grade 2 or higher adverse events associated with ibrutinib and venetoclax therapies
Adverse event . | Grade 2 . | Grade 3 . | Grade 4 . | Grade 5 . |
---|---|---|---|---|
Alanine aminotransferase increase | 1 | |||
Anemia | 1 | |||
Anorexia | 1 | |||
Arthralgia | 5 | 1 | ||
Atrial fibrillation | 1 | 2 | ||
Bruising | 2 | |||
Diarrhea | 11 | 3 | ||
Fatigue | 2 | 1 | ||
Gastroesophageal reflux disease | 12 | |||
Headache | 1 | |||
Hematoma | 1 | |||
Hematuria | 1 | |||
Hyperphosphatemia | 8 | |||
Hypertension | 2 | 1 | ||
Hyponatremia | 1 | |||
Intracranial hemorrhage | 1 | |||
Lung infection | 2 | |||
Malaise | 1 | |||
Mucositis | 9 | 4 | ||
Myalgia | 3 | |||
Nausea | 5 | |||
Neutropenia | 2 | 13 | 4 | |
Platelet decrease | 1 | |||
Skin rash | 5 | |||
Soft tissue infection | 2 | 1 | ||
Tumor lysis syndrome | 3 | |||
Upper respiratory infection | 4 | |||
Urinary tract infection | 5 | |||
Ventricular arrhythmia | 1 | 1 | 2 |
Adverse event . | Grade 2 . | Grade 3 . | Grade 4 . | Grade 5 . |
---|---|---|---|---|
Alanine aminotransferase increase | 1 | |||
Anemia | 1 | |||
Anorexia | 1 | |||
Arthralgia | 5 | 1 | ||
Atrial fibrillation | 1 | 2 | ||
Bruising | 2 | |||
Diarrhea | 11 | 3 | ||
Fatigue | 2 | 1 | ||
Gastroesophageal reflux disease | 12 | |||
Headache | 1 | |||
Hematoma | 1 | |||
Hematuria | 1 | |||
Hyperphosphatemia | 8 | |||
Hypertension | 2 | 1 | ||
Hyponatremia | 1 | |||
Intracranial hemorrhage | 1 | |||
Lung infection | 2 | |||
Malaise | 1 | |||
Mucositis | 9 | 4 | ||
Myalgia | 3 | |||
Nausea | 5 | |||
Neutropenia | 2 | 13 | 4 | |
Platelet decrease | 1 | |||
Skin rash | 5 | |||
Soft tissue infection | 2 | 1 | ||
Tumor lysis syndrome | 3 | |||
Upper respiratory infection | 4 | |||
Urinary tract infection | 5 | |||
Ventricular arrhythmia | 1 | 1 | 2 |